Ligand Pharmaceuticals Incorporated
LGND News Today: Stay Updated with the Latest Ligand Pharmaceuticals Incorporated News in Real Time
Find LGND news now at Meyka AI. Stay informed with the latest Ligand Pharmaceuticals Incorporated stocks updates, including price news, market analysis, and expert insights.
ALNA stock drops 99% since IPO, trades at $0.075 on NASDAQ
ALNA stock trades at $0.075 with 252M volume. Allena Pharmaceuticals faces severe losses and declining valuations in biotech sector.
DCACS.AS stock shows 55% volume spike in pre-market trading Apr 25
DCACS.AS stock trades at €6.7 with 55% volume spike in pre-market. SPAC based in Guernsey shows unusual activity.
SURE.CN Stock Surges 1.85% on Volume Spike, 25 Apr 2026
SURE.CN stock rises 1.85% with volume spike to 803,263 shares. SureNano Science trades at C$0.275 on CNQ exchange.
ORINF Orion Oyj Earnings Miss: EPS Down 10.1%
Orion Oyj (ORINF) missed Q1 2026 earnings expectations with EPS of $0.74 vs. $0.82 estimate and revenue of $482.6M vs. $492.4M forecast.
CSL Carlisle Companies Earnings Beat: EPS Tops Estimates
Carlisle Companies beat EPS estimates with $3.63 vs $3.31 expected, but missed revenue at $1.05B. Stock down 1%.
SNA Snap-on Earnings: Beat Revenue, Missed EPS April 2026
Snap-on (SNA) Q1 2026 earnings: Beat revenue at $1.21B (+2.53%), missed EPS at $4.69 (-1.26%). Stock down 3.16%.
2107.T Stock Shows 186% Volume Spike in Pre-Market Trading Apr 25
2107.T (Toyo Sugar Refining) surges 186% above average volume in pre-market JPX trading. Current price ¥2,073 with A+ rating.
HBANZ Huntington Bancshares Earnings Beat: Q2 2026 Results
Huntington Bancshares beat EPS estimates with $0.25 vs $0.2282 expected. Revenue hit $2.59B, surpassing forecasts.
HBANZ Huntington Bancshares Earnings Beat Q2 2026
Huntington Bancshares beat EPS by 9.55% and revenue by 0.98% in Q2 2026 earnings, posting $0.25 EPS versus $0.23 estimate.